Ferroportin in the progression and prognosis of hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is the fifth most common malignant tumor in men and the seventh in women and understanding the molecular mechanisms of HCC and establishing more effective therapies are critical and urgent issues. Our objective was to study the expression of ferroportin in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qin, Zhou, Jun, Zhong, Dewu, Wang, Qunwei, Huang, Jiangsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878504/
https://www.ncbi.nlm.nih.gov/pubmed/24360312
http://dx.doi.org/10.1186/2047-783X-18-59

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878504/
https://www.ncbi.nlm.nih.gov/pubmed/24360312
http://dx.doi.org/10.1186/2047-783X-18-59

Ejemplares similares